BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7673041)

  • 21. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
    van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Planned preoperative irradiation and surgery for advanced cancer of the oral cavity, pharynx and larynx.
    Roswit B; Spiro RH; Kolson H; Lin PY
    Am J Roentgenol Radium Ther Nucl Med; 1972 Jan; 114(1):59-62. PubMed ID: 5009416
    [No Abstract]   [Full Text] [Related]  

  • 23. Sixth interim progress report of the British Institute of Radiology fractionation study of 3F/week versus 5F/week in radiotherapy of the laryngo-pharynx.
    Wiernik G; Bleehen NM; Brindle J; Bullimore J; Churchill-Davidson IF; Davidson J; Fowler JF; Francis P; Hadden RC; Haybittle JL; Howard N; Lansley IF; Lindup R; Phillips DL; Skeggs D
    Br J Radiol; 1978 Apr; 51(604):241-50. PubMed ID: 647178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative review of the Hammersmith (1971-75) and Edinburgh (1977-82) neutron therapy trials of certain cancers of the oral cavity, oropharynx, larynx and hypopharynx. Medical Research Council Neutron Therapy Working Group.
    Br J Radiol; 1986 May; 59(701):429-40. PubMed ID: 3518846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
    Krstevska V; Crvenkova S
    Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival.
    Overgaard J; Hansen HS; Jørgensen K; Hjelm Hansen M
    Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):515-21. PubMed ID: 3700161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Late postradiation injury of the larynx in relation to the intensity of local reaction during x-ray treatment of the cancer of larynx and lower pharynx].
    Kuśnierczyk W; Betkowski A; Kwiatkowska A; Lepkowska H; Swiatnicka J
    Nowotwory; 1965; 15(2):173-9. PubMed ID: 5837032
    [No Abstract]   [Full Text] [Related]  

  • 28. Quantitative clinical radiobiology of early and late lung reactions.
    Bentzen SM; Skoczylas JZ; Bernier J
    Int J Radiat Biol; 2000 Apr; 76(4):453-62. PubMed ID: 10815624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiobiological prediction of normal tissue toxicities and tumour response in the radiotherapy of advanced non-small-cell lung cancer.
    Singer JM; Price P; Dale RG
    Br J Cancer; 1998 Dec; 78(12):1629-33. PubMed ID: 9862575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer of the larynx and pharynx.
    Trible WM; Kahaner H
    Arch Otolaryngol; 1969 Apr; 89(4):617-9. PubMed ID: 5766753
    [No Abstract]   [Full Text] [Related]  

  • 31. Elective lymph node irradiation with intensity-modulated radiotherapy: is conventional dose fractionation necessary?
    Bedi M; Firat S; Semenenko VA; Schultz C; Tripp P; Byhardt R; Wang D
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e87-92. PubMed ID: 22516389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiotherapy alone for oropharyngeal carcinomas: the role of fraction size (2 Gy vs 2.5 Gy) on local control and early and late complications.
    Thomas F; Ozanne F; Mamelle G; Wibault P; Eschwege F
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1097-102. PubMed ID: 3182341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.
    van Leeuwen CM; Oei AL; Crezee J; Bel A; Franken NAP; Stalpers LJA; Kok HP
    Radiat Oncol; 2018 May; 13(1):96. PubMed ID: 29769103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology.
    Withers HR; Peters LJ; Taylor JM; Owen JB; Morrison WH; Schultheiss TE; Keane T; O'Sullivan B; van Dyk J; Gupta N
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):563-8. PubMed ID: 7558944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study.
    Overgaard J; Hansen HS; Andersen AP; Hjelm-Hansen M; Jørgensen K; Sandberg E; Berthelsen A; Hammer R; Pedersen M
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1065-8. PubMed ID: 2649462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal tissue reactions in the British Institute of Radiology Study of 3 fractions per week versus 5 fractions per week in the treatment of carcinoma of the laryngo-pharynx by radiotherapy.
    Rezvani M; Alcock CJ; Fowler JF; Haybittle JL; Hopewell JW; Wiernik G
    Br J Radiol; 1991 Dec; 64(768):1122-33. PubMed ID: 1773272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
    Garden AS; Morrison WH; Ang KK; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
    Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose intensification in curative head and neck cancer radiotherapy--linear quadratic analysis and preliminary assessment of clinical results.
    McGinn CJ; Harari PM; Fowler JF; Ford CN; Pyle GM; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):363-9. PubMed ID: 8407411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of dose per fraction and estimation of an alpha/beta value for the late complications of the vocal cord.
    Deore SM; Supe SJ; Sharma V; Dinshaw KA
    Strahlenther Onkol; 1991 Oct; 167(10):608-11. PubMed ID: 1948646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.